Adimmune Corporation (TPE:4142)

Adimmune Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,763	2,345	2,458	2,857	2,652	4,087
Short-Term Investments	24.5	112.5	12.5	100.5	239	337.06
Cash & Short-Term Investments	1,788	2,457	2,470	2,958	2,891	4,425
Cash Growth	-3.29%	-0.52%	-16.49%	2.30%	-34.66%	302.92%
Accounts Receivable	442.48	187.81	1,308	534.97	99.64	109.75
Other Receivables	38.68	39.76	30.51	43.09	111.22	5.73
Receivables	481.17	227.57	1,339	578.06	210.86	115.48
Inventory	910.15	764.59	682.33	815.94	602.1	302.05
Prepaid Expenses	13.78	6.45	8.19	4.42	4	165.46
Other Current Assets	190.46	154.27	200.21	135.34	88.02	39.07
Total Current Assets	3,383	3,610	4,699	4,491	3,796	5,047
Property, Plant & Equipment	3,974	3,818	3,613	3,641	3,447	2,352
Long-Term Investments	93.73	109.66	105.86	100.25	119.34	137.08
Other Intangible Assets	21.89	34.46	51.11	67.98	85.82	101.69
Long-Term Accounts Receivable	334.93	334.93	334.93	326.66	137.37	-
Long-Term Deferred Tax Assets	227.42	227.42	227.6	227.59	228.03	227.89
Long-Term Deferred Charges	8.94	13.4	19.36	25.32	31.27	37.23
Other Long-Term Assets	336.07	333.93	433.57	268.29	165.53	570.66
Total Assets	8,381	8,481	9,484	9,149	8,010	8,473
Accounts Payable	51.09	31.25	42.35	48.84	5.88	23.46
Accrued Expenses	171.93	164.26	126.85	192.83	145.77	120.11
Short-Term Debt	527.5	500	540	20	-	-
Current Portion of Long-Term Debt	1,028	320.04	669.93	125.01	41.09	2.07
Current Portion of Leases	21.78	19.02	14.71	16.68	7.13	7.23
Current Unearned Revenue	9.39	9.39	21.81	11.11	23.44	167.91
Other Current Liabilities	19.29	117.35	371.3	86.02	73.73	204.63
Total Current Liabilities	1,829	1,161	1,787	500.49	297.04	525.41
Long-Term Debt	1,647	1,705	1,869	2,039	1,266	1,307
Long-Term Leases	48.74	52.33	48.71	61.65	6.34	7.13
Pension & Post-Retirement Benefits	-	-	-	-	-	4.11
Other Long-Term Liabilities	2.61	0.84	1.94	2.35	7.95	0.77
Total Liabilities	3,527	2,920	3,707	2,604	1,578	1,845
Common Stock	4,295	4,295	4,295	4,295	4,295	4,295
Additional Paid-In Capital	829.5	829.5	835.41	849.05	855.12	830.21
Retained Earnings	-134.93	351.19	597.61	1,238	944.84	1,123
Treasury Stock	-292.54	-292.54	-292.54	-292.54	-	-
Comprehensive Income & Other	28.67	49.49	38.94	34.62	53.79	68.03
Total Common Equity	4,726	5,233	5,475	6,124	6,149	6,316
Minority Interest	127.28	328.97	303.07	421.07	283.72	312.5
Shareholders' Equity	4,853	5,562	5,778	6,545	6,433	6,629
Total Liabilities & Equity	8,381	8,481	9,484	9,149	8,010	8,473
Total Debt	3,273	2,597	3,143	2,263	1,321	1,324
Net Cash (Debt)	-1,485	-139.56	-672.63	695.03	1,570	3,101
Net Cash Growth	-	-	-	-55.74%	-49.36%	-
Net Cash Per Share	-3.52	-0.33	-1.60	1.63	3.66	7.56
Filing Date Shares Outstanding	421.51	421.51	421.51	421.51	429.51	429.51
Total Common Shares Outstanding	421.51	421.51	421.51	421.51	429.51	429.51
Working Capital	1,555	2,449	2,912	3,991	3,499	4,521
Book Value Per Share	11.21	12.41	12.99	14.53	14.32	14.71
Tangible Book Value	4,704	5,198	5,423	6,056	6,063	6,215
Tangible Book Value Per Share	11.16	12.33	12.87	14.37	14.12	14.47
Land	14.36	14.36	14.36	14.36	14.36	14.36
Buildings	2,148	2,143	2,138	2,117	2,108	2,141
Machinery	2,320	2,319	2,332	2,255	1,999	2,529
Construction In Progress	1,637	1,379	1,029	1,100	1,032	317.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.